MetLife Investment Management’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
KL
OCMI
NIM
GKFF
MetLife Investment Management's ASPN Position: Q2 2026 in Review
MetLife Investment Management increased its Aspen Aerogels (ASPN) stake by 166% in Q2 2026, buying an estimated $123K and bringing the position to 40,269 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #2296.
MetLife Investment Management first reported a position in ASPN in Q3 2020 and has held it in 24 quarters since. The position peaked at $4.88M in Q1 2025. 179 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.
- MetLife Investment Management held 40,269 shares of Aspen Aerogels worth $255K as of Q2 2026.
- MetLife Investment Management bought 25,151 Aspen Aerogels shares in Q2 2026, an estimated $123K.
- Aspen Aerogels made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2296 holding.
- MetLife Investment Management first reported a position in Aspen Aerogels in Q3 2020 and has held it in 24 quarters since.
- MetLife Investment Management's Aspen Aerogels position peaked at $4.88M in Q1 2025.
- 179 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.